Skip to content

Managing weight in obese patients before heart surgery to see if this improves the effects of surgery

Pre-operative weight management to improve outcomes of cardiac surgery in adults with obesity (SLIM-CARD): a multicentre feasibility RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16012660
Enrollment
174
Registered
2021-05-06
Start date
2022-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-operative weight management to improve outcomes of cardiac surgery in adults with obesity Nutritional, Metabolic, Endocrine

Interventions

MONTHS 1 - 4 (approx.) ALL SITES BEHAVIOURAL STUDY 1: This will involve interviewing patients and healthcare professionals about their thoughts around cardiac surgery and recruitment into a trial invo
sharing these with the behavioural researcher who will call the patient at a convenient time (but within 24-48 hours of the clinic appointment) and conduct the interview over the telephone and audio r
research nurses will use it during the initial discussion with participants and this will be audio recorded and qualitatively analysed. The Clinical Trial will also commence, with patients being rando

Sponsors

University of Leicester
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients (>17 years) referred for cardiovascular surgery. 2. Patients who have obesity; defined as BMI=30 for patients of White-European ethnicity and as BMI=27.5 for all other ethnic groups. 3. Willingness and ability to commit to up to 12 weekly sessions of the intervention or to commit to weight stability. 4. Behavioural Study 1: Willingness to be interviewed within 24-48 hours of the clinic appointment and have the interview audio recorded.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing urgent or emergency surgery. 2. Patients who are participating in another interventional trial. 3. Patients who are currently/ recently (<3m) enrolled in a weight management programme.

Design outcomes

Primary

MeasureTime frame
Feasibility outcomes: 1. Number of participants randomised to the intervention arm attending =75% sessions measured using case report forms at 1-day pre-op 2. Number of participants randomised to the control arm whose weight at surgery remains within 1.5kg of their baseline weight (measured as below point 3) at 1-day pre-op Efficacy outcome: 3. Weight (kg) baseline and 1-day pre-op measured using weighing scales

Secondary

MeasureTime frame
1. Recruitment rate, attrition rate, data completeness at end of study measured using case report forms 2. A composite endpoint of ischaemic organ injury: low cardiac output, acute kidney, brain or gut injury at day 5 post op measured using clinical observation and blood tests 3. A composite endpoint of infection: surgical site infection, lower respiratory tract infection, urinary tract infection, sepsis at day 5 post op measured using clinical observation and blood tests 4. Adverse events, including mortality, collected from randomisation to 3 months post-surgery at day 5 post op, 6 weeks and 3 months using case report forms 5. Quality of life measured at baseline, 1-day pre-operation and 3 months using the EQ-5D-5L 6. Resource use up to 3 months post-surgery estimated from a bespoke questionnaire at 5 post op, 6 weeks and 3 months

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026